MediPal (OTCMKTS:MAHLY – Get Free Report) was downgraded by equities research analysts at Citigroup from a “buy” rating to a “neutral” rating in a note issued to investors on Thursday, FlyOnTheWall reports. MediPal Stock Performance Shares of OTCMKTS:MAHLY opened at $17.19 on Thursday. MediPal has a 12 month low of $12.06 and a 12 month […]